Background
• Uterine carcinosarcoma (UCS) is an aggressive cancer with a poor prognosis.
• There are limited studies evaluating the molecular stratification of UCS or its association with survival outcomes.
• No survival comparisons exist between UCS and endometrioid endometrial cancer (EEC) according to molecular classification.